LAFAYETTE, La., Oct. 4, 2018 /PRNewswire/ -- Patients
suffering from chronic obstructive pulmonary disease (COPD) with
chronic respiratory failure (CRF) using home non-invasive
ventilation (NIV) live longer, are less likely to be admitted to a
hospital and cost Medicare significantly less than patients using
other devices.
These are the recently released findings from a study of four
years of Centers for Medicare and Medicaid Services (CMS) data
analyzed by KPMG, a global audit, tax, and advisory firm, and
VieMed (TSX:VMD), a leading provider of post-acute home respiratory
services, which commissioned the report.
"The evidence is clear," said VieMed's CEO Casey Hoyt. "Using a non-invasive ventilator at
home coupled with a high-touch home care model saves lives, saves
money, and keeps patients out of the hospital. It is time for both
medical practice and health insurers, including Medicare, to catch
up with changes in technology. Since the introduction of modern
highly sophisticated home ventilators within the last decade, NIV
has become the gold standard for treating patients in the late
stages of COPD."
The KPMG study, "CRF/COPD 4-year CMS Data Comparison of
Mortality & Cost, (2013-2016)," examined the costs and the
benefits of the various respiratory assistive devices physicians
commonly prescribe for patients suffering from COPD with CRF. A
chief finding was that patients using NIV at home with a high-touch
care model have the lowest overall costs and hospitalization rates.
A high-touch care model includes multiple home visits by a
certified respiratory therapist, 24-hour access to medical
professionals, and enhanced coordination with physicians and other
clinicians.
COPD is a chronic condition that affects as many as 24 million
Americans and is the country's third-leading cause of death, after
cancer and congestive heart failure. Treating patients diagnosed
with this progressive, chronic condition also costs the country
more than $30 billion a year. The
KPMG study offers compelling evidence that both outcomes and costs
can be improved through home NIV with a high-touch care model.
Outcome and Cost Improvements
Specifically, the study
examined results of untreated patients who used no respiratory
device at home, patients using a bi-level positive airway pressure
device (BPAP), and patients using a NIV. The study looked at
mortality, the number of times patients were hospitalized and the
total cost of caring for patients in each group.
The analysis found that patients using a BPAP or NIV lived
longer than untreated patients. For example, only 22 percent of
COPD patients with CRF using NIV died, compared to 38 percent of
untreated patients. Although there was little difference in the
overall death rates between patients using a BPAP or NIV, there
were significant differences in the cost of treating these patients
and hospitalization rates.
For example, over a six-month period:
- Patients with no ventilation support cost CMS $41,000
- Patients using a BPAP cost $39,000
- Patients using NIV coupled with a high-touch care model cost
$29,000
- 25 percent of untreated patients were admitted to a
hospital
- 26 percent of patients using a BPAP were admitted to a
hospital
- Less than 20 percent of patients using NIV and receiving
high-touch care model were admitted to the hospital
"The KPMG study is one of the most important studies of this
issue to date," said VieMed Chief Medical Officer and pulmonologist
William Frazier, MD. "It should help
physicians and others make informed decisions about the best
approach to treating patients suffering from COPD."
About VieMed Healthcare, Inc.
VieMed, through its
indirect wholly-owned subsidiaries Sleep Management, L.L.C., and
Home Sleep Delivered, L.L.C., is a home medical equipment supplier
that provides post-acute respiratory care services in the United States. Sleep Management, L.L.C.
focuses on disease management and improving the quality of life for
respiratory patients through clinical excellence, education, and
technology. Its service offerings are based on effective home
treatment with Respiratory Therapists providing therapy and
counseling to patients in their homes using cutting edge
technology. Home Sleep Delivered focuses on providing in-home sleep
testing for sleep apnea sufferers. Visit our websites at
www.viemed.com and www.homesleepdelivered.com.
Media
Contacts:
|
|
Linda
Healan
|
Ryan
Sullivan
|
Amendola
Communications
|
VieMed Healthcare,
Inc.
|
404-725-7117
|
866-852-8343
x131
|
Lhealan@acmarketingpr.com
|
Rsullivan@viemed.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/a-recent-kpmg-study-supports-that-home-non-invasive-ventilation-for-copd-reduces-costs-and-hospitalizations-300724122.html
SOURCE VieMed